Information on results of RFP 20999 - REAGENTS AND LABORATORY ACCESSORIES

REQUEST FOR PROPOSAL

RFP 20999 - REAGENTS AND LABORATORY ACCESSORIES

In connection with the co-financing of the project entitled „Development of novel mRNA/VLP-based vaccines against emerging zoonotic viral diseases ”financed by the State budget from the Medical Research Agency (no. 2021 / ABM / 05 / 00001-00) as part of the Competition: Development of innovative therapeutic solutions using RNA technology, pursuant to § 8 sec.2 point 2) of the co-financing agreement, Adamed Pharma S.A. informs that the contract will be awarded to the following companies that have presented the most advantageous offer:

Life Technologies Polska Sp. z o.o. items: 1, 2, 3, 11, 12, 13, 21, 22, 23, 25, 29, 30, 35, 37

Merck Life Science Sp. z o.o. items: 8, 14, 16, 18, 19, 20, 24, 26, 27, 32, 36, 39

ALAB Spółka z ograniczoną odpowiedzialnością item: 31

Cytogen Polska Sp. z o.o items: 17, 43, 44, 45

Lab-JOT Ltd. Sp. z o.o. Sp.k. items: 10

Undecided for items: 4, 5, 6, 7, 9, 15, 28, 33, 34, 38, 40, 41, 42